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ORIGINAL ARTICLE
Clinical Assessment of a Customized Free-Form
Progressive Add Lens Spectacle
Susan C. Han*, Andrew D. Graham†, and Meng C. Lin‡
ABSTRACT
Purpose. To determine whether there are significant differences in standard clinical measures of vision, progressive
addition lens (PAL)-specific vision tests, or subjective ratings and preferences between customized free-form and standard
non-free-form PALs in an experienced wearing population. In addition, we aim to determine whether subjective or
objective clinical outcomes depend on demographic, PAL usage, spectacle prescription, or frame fitting characteristics.
Methods. In a randomized, double-masked cross-over trial, 95 experienced wearers wore Zeiss Individual customized
free-form PAL spectacles (test) and standard non-free-form PAL spectacles (control) for 1 week each. At dispensing and
after 1 week of wear, subjects were tested for distance and near visual acuity under both high and low contrast; in
addition, 30° off-axis visual acuity was measured using a novel apparatus, as was the horizontal extent of clear,
undistorted vision at reading distance. Subjects also completed a set of questionnaires detailing their satisfaction levels,
adaptation times, and preferences for test or control spectacles for different visual tasks.
Results. The test spectacles were preferred overall and for distance, midrange, transitional and active vision, and rated
higher in overall satisfaction (p  0.006). There were no clinically important differences between test and control
spectacles in standard clinical vision assessments. In the PAL-specific assessments, however, the horizontal extent of clear
vision at reading distance was significantly greater with the test spectacles (p  0.004).
Conclusions. There were statistically significant preferences for the optically customized free-form lenses over the
non-free-form lenses. Subjects also reported a wider field of undistorted vision when looking through the reading zone
of the test spectacles. Although standard clinical vision assessments are not sufficiently refined to detect important
objective differences between the spectacle types, customization taking into account back vertex distance, segment
height, pantoscopic tilt, and wrap angle can result in a superior subjective wearing experience for many PAL patients.
(Optom Vis Sci 2011;88:234–243)
Key Words: progressive addition lenses, customized free-form, presbyopia, bifocals, subjective assessment, visual
performance, visual acuity, Amsler grid
Progressive addition lenses (PALs) offer several advantagesover-lined bifocal or multifocal lenses, including the contin-uous transition in addition power from a zone focused for
distance vision in the upper region of the lens to a near vision zone
in the lower part of the lens, without visible lines of demarcation.
Previous studies have compared patients’ satisfaction with progres-
sive lenses to that with other types of presbyopic correction and
found that the majority of subjects preferred progressive lenses.1–3
Nevertheless, progressive lenses still prove difficult for some pa-
tients to adapt to, and many patients prefer to remove their PAL
spectacles for certain tasks, suggesting the potential for an im-
proved clinical outcome. In one study that examined the various
types of corrections for presbyopia, progressive lens wearers were
more satisfied than bifocal lens wearers with driving, and yet PAL
wearers also reported distortion of their peripheral vision.4 Pro-
gressive surfaces produce a smooth, continuous change in addition
power by “blending” the peripheral regions of the lens surface
through the use of surface astigmatism. Significant surface astig-
matism results in unwanted blur, image distortion, and a sensation
of motion, swim or vertigo, particularly when transitioning
abruptly to focus at different distances, or when viewing the envi-
ronment through the aberrated periphery of the lens. Although
this inherent surface astigmatism is generally minimized to its
mathematical limits in modern progressive lens designs, traditional
progressive lenses still suffer from the optical compromises of mass
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lens production, which commonly relies on making a relatively
small number of unique lens designs work sufficiently well for a
large population of wearers with diverse visual requirements. These
optical compromises can exacerbate the unwanted astigmatism ef-
fects of the progressive lens by introducing additional focusing
errors, reducing the overall satisfaction level of the patient, and
preventing some patients from adjusting to the lenses.
The use of a limited number of base curves or unique optical
designs also results in residual optical aberrations in the periphery
of the lens.5 The position of the fitted spectacles can introduce
additional prescription errors through both the central and periph-
eral regions of the lens because of the effects of lens tilt.6 These
residual optical aberrations are particularly problematic with pro-
gressive lenses because oblique astigmatism interacts with the sur-
face astigmatism inherent in the lens design, resulting in narrower
and often distorted viewing zones. Because of the mathematical
constraints of progressive surfaces, the use of only one or two
corridor lengths results in either unnecessarily narrow viewing
zones if the corridor is longer than necessary or insufficient reading
utility if the corridor is shorter than necessary.7 Traditional man-
ufacturing relies on a mass production process in which a small
number of initial progressive lens designs are optically optimized
for relatively broad categories of wearers by assuming an average
prescription power, fitting geometry, and frame size for each lens
design. Uncorrected optical aberrations therefore occur in the final
lens as a result of differences between the actual prescription or
position of wear and the values assumed during the calculation
process. Because traditional lens surfacing is limited to basic spher-
ical and spherocylindrical (toric) lens surfaces, no further optical
optimization can be applied.
Recent breakthroughs in the lens manufacturing process have
created the opportunity for lens manufacturers to further minimize
these optical aberrations, with the desired effect of improving pa-
tient acceptance and satisfaction.8 Manufacturers have begun in-
troducing progressive lenses with one or both surfaces fabricated
using a free-form surfacing process, which can produce surfaces of
significantly greater complexity. Although free-form surfacing can
be used to manufacture traditional progressive lenses, it is also
being used in conjunction with advanced optical design software to
produce a surface that modifies the initial lens design based on the
specific visual requirements of each wearer. The software uses the
fitting characteristics of the frame on the patient in creating indi-
vidually customized free-form progressive lenses. PAL spectacles
can be customized by incorporating the wearer’s individual vertex
distance, pantoscopic tilt, frame wrap, and frame size measure-
ments during the optical optimization process to reduce aberra-
tions caused by the specific prescription and fit of the spectacles on
the patient. It is thought that customized lens designs delivered via
free-form PAL processing could lead to improvements such as
wider distance/intermediate/reading areas, reduced blur, and in-
creased image sharpness.8
Studies have been conducted to determine whether various pro-
gressive lens designs outperform others. For example, the study of
Borish and the VEPRO trial compared newer progressive lenses to
older designs, in randomized cross-over trials.9,10 To our knowl-
edge, however, there has not been a randomized cross-over trial
comparing customized free-form progressives to traditional (non-
free-form) progressives to date. In this study, we compare lenses
which are optically customized for each wearer’s prescription re-
quirements, position of wear, and frame size before fabrication
using free-form lens surfacing to traditional PALs, which are fab-
ricated from a factory-molded progressive lens blank using tradi-
tional lens surfacing with a conventional spherocylindrical (toric)
surface. In this study, we aim to determine whether there are sig-
nificant differences in standard clinical measures of vision, PAL-
specific vision tests, and/or subjective ratings and preferences
between customized free-form and standard progressive lenses in
an experienced PAL wearing population. In addition, we aim to
determine whether objective or subjective clinical outcomes de-
pend on demographic, PAL usage, spectacle prescription, or frame
fitting characteristics.
METHODS
Study Design
This study was a randomized, double-masked cross-over trial
comparing a customized free-form progressive lens spectacle to
standard non-free-form progressive lens spectacles in an experi-
enced PAL wearing population. Subjects wore test and control
spectacles for 1 week each, and completed clinical vision assess-
ments and questionnaires at baseline and after 1 week of wear of
each pair of study spectacles. The order of wear of the test and
control spectacles was randomized, and the subjects, the optome-
trists, and the technicians administering any measurements or
questionnaires were masked as to which type of spectacle was being
worn at each visit.
Subject Recruitment
Presbyopic subjects were recruited from the population of pa-
tients who were purchasing non-free-form PAL spectacles with
antireflective coating in new frames from the University of Cali-
fornia, Berkeley School of Optometry Eyewear Center. Subjects
were all experienced progressive lens wearers. Subjects purchasing
free-form PALs were excluded from participation. The sample size
required for this study was not formally estimated; 100 subjects
were requested by the trial sponsor based on their own preliminary
data. After designing all aspects of the trial, we performed a pilot
run of 13 subjects to ensure that all questionnaire and laboratory
data could be collected on 100 subjects within the time frame of
the trial. On the basis of the data from sponsor and our pilot, we
determined that a sample size of 100 subjects would be more than
sufficient to detect any clinically meaningful differences should
they exist. In post hoc testing, we determined that the 95 subjects
completed would allow us to detect a 0.02 logarithm of the
minimum angle of resolution (logMAR) difference between spec-
tacles with 95% confidence and 80% power. On selection of PAL
spectacles and frames, potential subjects were referred to the Uni-
versity of California, Berkeley Clinical Research Center, where
they were informed about the trial. Subjects expressing interest in
participating, had their examination records sent to the Clinical
Research Center, where they were verified to ensure that the sub-
jects were correctable to at least 20/25 in both eyes and did not
have any eye conditions or diseases that could potentially cause a
decrease in visual acuity (VA) during the course of their participa-
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tion in the study or affect their ability to use PALs as their primary
form of vision correction.
Test and Control Spectacles
The test spectacles used were Zeiss Individual, fitted using the
i.Terminal (Carl Zeiss Vision, Germany). The i.Terminal is a dig-
ital video centration device that automatically measures various
fitting characteristics for the individual subject and chosen frame,
including frame wrap angle, pantoscopic tilt, and back vertex distance,
that are not part of the standard fitting parameters for PAL spectacles.
Subjects were required to have prescriptions within the ranges of lenses
and materials available for the Zeiss Individual. Available materials
included CR39 (allyl diglycol carbonate, PPG Industries, Pittsburgh,
PA), polycarbonate and 1.67 (high index plastic), available in clear or
photochromic (gray or brown). For the CR39 material, available
sphere powers ranged from5.0 diopters (D) to6.0 D, with add
powers from0.75 D to3.5 D for clear lenses, and to3.0 D for
photochromic lenses. The polycarbonate and 1.67 materials ranged in
sphere power from 6.0 D to 10.0 D, with available add powers
ranging from0.75 D to3.5 D for polycarbonate, and to3.0 D
for the high index material. Maximum cylinder power for all lenses
was4.0 D.
The non-free-form control pair was chosen by the subject at the
Eyewear Center, before being informed about the study, from a
variety of popular PAL brands after considering a combination of
factors, including prior PAL wearing history and recommenda-
tions from the fitting optician and optometric clinician according
to standard practice. The non-free-form PAL brands included So-
lamax, AO Compact, Hoyalux Summit, Kodak Concise, Kodak
Precise, Ovation, Proceed, Comfort Ellipse, Panamix, GT2, Vari-
lux Physio, and Gradal Top. The final distribution of PAL brands
across subjects was similar to the distribution of these brands
among all patients of the Eyewear Center. The test and control
spectacles were manufactured with identical prescriptions, monoc-
ular pupillary distances, segment heights, lens materials, frames,
and antireflective coating. To adhere to the standard PAL spectacle
fitting practices of dispensing opticians, the pupillary distance was
measured using an automated pupillometer, and segment height
was measured manually. The two pairs of study spectacles differed
in base design, free-form surfacing of the test lenses, and the addi-
tional optical customization of the test lenses based on individual
prescription, frame size, and i.Terminal measurements. American
Board of Opticianry-certified opticians who were trained and cer-
tified by the Clinical Research Center to operate the i.Terminal
used this instrument to measure the additional fitting parameters,
which included pantoscopic tilt, back vertex distance, and frame
wrap angle. These additional measurements were supplied only to
the laboratory manufacturing the test lenses. Both pairs of study
spectacles were verified on receipt to ensure that they had been
manufactured correctly.
Before initiating recruitment for the main trial, we conducted a
repeatability and reproducibility study of the spectacle fitting pa-
rameters generated by our opticians. After a sufficient period of
optician training on the i.Terminal, three volunteer subjects wear-
ing test frames had fitting measurements taken by the five opticians
involved in the trial, in random order, which were repeated on the
following day. We constructed limits of agreement, examined
difference-vs.-means and a variety of other plots, and conducted
variance component analyses, to ensure that our manual pupillary
distance and segment height measurements, and the back vertex
distance, pantoscopic tilt, and frame wrap angle generated by the
i.Terminal were repeatable and reproducible.
All subjects were oriented as to the goals, risks, and benefits of
the study before signing a consent form. Subjects paid for their
Control lenses and frames as normal in the Eyewear Center, before
being informed about the study. Subjects who were eligible and
elected to participate in the trial were compensated at the end of
the trial with the Zeiss Individual lenses in an identical frame and
a $50.00 gift certificate for the University of California, Berkeley
School of Optometry Clinic. This study adhered to the tenets of
the Declaration of Helsinki and was approved by institutional
review board. In accordance with the recommendations of the
International Committee of Medical Journal Editors, we have reg-
istered this clinical trial (URL: www.clinicaltrials.gov).
Standard Clinical Assessments of Vision
Distance visual acuities under both high (100%) and low
(10%) contrast were measured using the M&S Technologies
(Dallas, TX) Smart System two projection system. The M&S
Technologies system is a computerized vision testing system based
on the Early Treatment Diabetic Retinopathy Study (ETDRS)
letter set, with a logarithmic progression of equally spaced rows
separated by 0.1 log units. For letters that are 20/63 and smaller,
there are five letters per row; for letters 20/80 and greater, the
number of letters per row changes because of the limits of screen
size. This electronic ETDRS protocol was approved by Food and
Drug Administration for use in clinical trials and has the advantage
that presentation of letters can be randomized to prevent subjects
from memorizing the chart from one visit to the next. Binocular
near VA was measured at 40 cm using ETDRS near charts in both
high and low contrast. We used multiple versions of the near charts
so that patients could not memorize the letters on the charts from
one visit to the next. VA was recorded as logMAR.
Novel PAL-Specific Assessments of Vision
An apparatus was created specifically for this study. It consisted
of a forehead and chin rest securely mounted on an adjustable
testing table. For each subject, the apparatus was adjusted for max-
imum head stability and immobilization, while maintaining ac-
ceptable subject posture and comfort. Adjustment parameters
included the height of apparatus from the floor, chin rest height,
positions of right and left temple stabilizing pads, and the vertical
and transverse distances and viewing angle of the reading surface,
all of which were adjusted individually for each subject to achieve
a normal and comfortable posture. Adjustment parameters were
recorded at the first visit for each subject, and the apparatus was
reset to these same parameter values for all subsequent visits. The
apparatus was used for distance VA under high and low contrast
using the ETDRS charts at viewing positions 30° off axis to the
right and left sides. Multiple versions of the ETDRS charts were
used so that subjects could not memorize the letters on the charts
from one visit to the next. For off-axis viewing, subjects were
monitored to ensure that their heads remained immobilized in the
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on-axis position, and that they could move only their eyes to view
the ETDRS charts from 30° to the periphery.
The testing apparatus was also used to measure the horizontal
extent of undistorted near vision, which was assessed using a mod-
ified grid, similar to the Amsler grid, which had been elongated to
a width of 60 cm and a height of 10 cm, with 1 point thickness
black lines spaced at 0.5 cm. Extensive preliminary testing was
done to determine the optimal width, height, line thickness and
spacing, line and background colors, and central reference marking
for PAL-wearing volunteers to most easily and reliably indicate the
point at which peripheral viewing became aberrated. Subjects were
positioned in the apparatus as described above and could then
move only their eyes to the right and left sides to indicate with a
finger the extent of undistorted vision at reading distance through
the near zone of the PAL spectacles, which was recorded by a
technician from a numerical scale printed along the grid edge
where it was not visible to the subject. The ambient light condition
was kept constant for all visits.
Questionnaires
Questionnaires asking subjects to rate each pair of spectacles on
a 0 to 100 scale (100  excellent overall satisfaction), to indicate
how long it took to adapt to each pair, and to give a strength of
preference for the test or control spectacles on a 6-point forced
choice Likert scale, were administered at each visit. Subjects were
masked as to which were the randomly assigned test and control
pairs, which were referred to on questionnaires only as study pair 1
and study pair 2. In addition, a final exit questionnaire asked the
subjects to choose one pair of spectacles or the other as their pref-
erence for distance, midrange, and near vision, as well as for tran-
sitional visual tasks, active vision, and overall preference. Results
from these commonly used types of rating and preference ques-
tionnaires are presented in this article.
In addition to the questionnaires described above, a novel ques-
tionnaire instrument was designed, using Rasch analysis, to assess
the subjective visual experience with PALs. This lengthy question-
naire assessed subjects’ visual quality, visual comfort and awareness
of their lenses at varying distances, under different viewing condi-
tions, and for a wide array of visual tasks. A complete description of
this questionnaire, the Rasch analysis, and final outcomes will be
presented in a subsequent article.
Study Protocol
Three visits were required for all subjects. Subject recruitment as
well as initial fitting and dispensing of both pairs of spectacles were
conducted by certified opticians in the Eyewear Center. The other
objective and subjective clinical measures as described above were
conducted by Clinical Research Center optometrists and staff. The
initial/screening visit included the selection of new glasses, recruit-
ment for the study, and signing of the consent form. Once consent
was obtained, the research optometrist confirmed subject eligibil-
ity for the study and the test spectacle orders were processed. Once
both pairs of spectacles had been received, the three main study
visits were scheduled. At visit 1, subjects completed a questionnaire
regarding their habitual spectacles. Pair 1 spectacles (test or con-
trol, according to the randomization assignment) were dispensed
and all the standard clinical test data and novel PAL-specific test
data (discussed above) were collected. At visit 2, the same battery of
tests was repeated for pair 1 after 1 week of wear. The subject then
returned pair 1 and received pair 2. The same tests were conducted
for pair 2. At visit 3, the same sequence of tests was conducted for
pair 2 after 1 week of wear. On exiting the study, subjects were
asked to choose the best pair of spectacles for several different
viewing distances and tasks. They were given both pairs of specta-
cles, marked only as pair 1 and pair 2, so they could refresh their
memories of their wearing experiences.
Statistical Analysis
Data were first subjected to an exploratory data analysis, in
which descriptive statistics were calculated, paired t-tests were per-
formed, and a variety of plots of the data were examined to screen
for data entry errors or other outliers. Mixed effects multivariate
models were then fit, with a single random effect to account for the
correlation between eyes within subjects, and fixed effects for the
independent variables including demographics, PAL usage, spec-
tacle prescription, and frame fitting characteristics. Final models
were chosen based on estimated effect sizes, F-test p-values,
Aikake’s Information Criterion and other model diagnostics, and
examination of residual and fitted value plots. All p-values reported
below are from the multivariate linear mixed effects analysis of
variance models unless otherwise noted.
RESULTS
We first conducted a preliminary analysis to ensure that both
our manual and i.Terminal fitting parameters were repeatable and
reproducible. We found that manual pupillary distance and seg-
ment height were highly repeatable, with a mean difference be-
tween repeated measurements of pupillary distance of 0.10 mm
[95% Limits of Agreement (0.74 to 0.94)], and a mean differ-
ence between repeated measurements of segment height of 0.26
mm [95% Limits of Agreement (1.57 to 2.08)]. We also found
that the five opticians maintained good agreement in their pupil-
lometer and manual segment height measurements on individual
subjects. The back vertex distance, pantoscopic tilt, and frame
wrap angle as measured by i.Terminal also showed repeatability
and reproducibility well within the ranges that would not make
any noticeable difference to the subjects in vision or wearing com-
fort. There were no patterns of the differences between repeated
measurements being related to their means, and the variability in
the data because of repeated measurements and interobserver dif-
ferences was a very small fraction of the total variance. From this
initial validation study, we concluded that our fitting parameter
measurements were highly repeatable and reproducible, and that
the new i.Terminal measurements would not introduce unwanted
variability in our outcome measures.
Ninety-five subjects were recruited and completed the trial.
Subjects were typical of the PAL-wearing population of the U.C.
Berkeley campus and surrounding community from which we
sampled. Subject’s age ranged in from 39 to 80 years, with a me-
dian age of 58 years. There were 57 females and 38 males, and all
except one subject had at least 2 years of postsecondary education.
Subjects were 77% white, 14% Asian, and 9% other ethnicities.
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PAL wearing history ranged from 1 to 25 years, with an average of
10 years. Nearly, all subjects wore their PAL spectacles on a daily
basis, for a median time of 13 h/d. Subjects averaged 4 h/d
computer usage, 2 h/d reading, and 1 h/d driving. Spectacle pre-
scription and fitting parameters are shown in Table 1.
Objective Findings
There were few differences between test and control spectacles
in any of the standard clinical vision assessments (Table 2). Dis-
tance VA under both high and low contrast, and near acuity under
high contrast were essentially the same, on average, for both spec-
tacle types, even after adjusting for any potential confounders.
Despite the fact that different subjects viewed the near chart
through slightly different parts of the lens (e.g., center of reading
zone; lower part of transition corridor) as a result of differing add
powers and a fixed 40 cm viewing distance; add power was not
significantly related near VA.
Near VA under low contrast after 1 week of wear was found to
be significantly associated with spectacle type (p  0.015), along
with prescription sphere (p 0.011), subject age (p 0.002), and
significant or near-significant interactions between spectacle type
and hours per day of PAL wear (p 0.006) and brand of control
spectacles (p  0.052). Overall, younger subjects with lower
sphere power (between4 D and3 D) prescriptions had better
low contrast near acuity. Although overall (i.e., unadjusted for any
other covariates), the control lenses performed marginally better in
near low contrast acuity (Table 2), the multivariate model suggests
that for subjects who wore their PAL spectacles on a continuous
basis (e.g., 19 h/d, the maximum we observed in our subjects), the
test spectacles performed better than the controls, but to a degree
that was of marginal clinical relevance. Depending on the specific
brand or brands of control spectacles compared, the improvement
in low contrast near VA with the test spectacles ranged from 0.02
to 0.05 logMAR (1 to 3 letters on the VA chart).
TABLE 1.
Prescription and fitting characteristics
Eyea Minimum Maximum Median Mean SD
Sphere OD 8.00 5.75 0.25 1.22 2.99
OS 8.25 5.25 1.00 1.24 2.93
Cylinder OD 3.50 0.00 0.75 0.87 0.78
OS 3.50 0.00 0.75 0.90 0.75
Add power OD 1.00 3.00 2.25 2.25 0.34
OS 1.00 3.00 2.25 2.25 0.34
Segment height OD 15.0 31.0 20.0 20.3 2.7
OS 15.0 31.0 20.0 20.4 2.7
Pupillary distance OD 27.0 36.0 31.0 31.2 2.0
OS 26.0 35.0 31.5 31.4 2.0
Back vertex distance 9.2 24.7 14.2 14.3 2.8
Pantoscopic angle 0.0 21.2 9.0 10.0 4.8
Wrap angle 1.2 15.0 7.3 7.5 3.4
Lens powers, segment height, and pupillary distance were taken using standard clinical methods. Back vertex distance, pantoscopic
angle, and wrap angle were taken using the i.Terminal and applied to the manufacture of the test spectacles only.
aBack vertex distance, pantoscopic angle, and wrap angle are characteristics of the frame fit on the subject and are not eye specific.
TABLE 2.
Standard clinical vision assessments
At fitting After 1 week of wear
Control
Mean (SD)
Test
Mean (SD) p
Control
Mean (SD)
Test
Mean (SD) p
Distance VA, HC (projector) 0.11 (0.07) 0.12 (0.06) 0.213 0.12 (0.06) 0.11 (0.07) 0.622
Distance VA, LC (projector) 0.01 (0.09) 0.01 (0.08) 0.705 0.01 (0.07) 0.01 (0.07) 0.425
Distance VA, HC (4m chart) 0.08 (0.09) 0.10 (0.14) 0.324 0.11 (0.13) 0.09 (0.09) 0.094
Distance VA, LC (4m chart) 0.05 (0.09) 0.06 (0.09) 0.275 0.05 (0.09) 0.12 (0.64) 0.293
Near VA, HC 0.03 (0.09) 0.03 (0.10) 0.886 0.04 (0.09) 0.03 (0.09) 0.250
Near VA, LC 0.15 (0.09) 0.15 (0.09) 0.715 0.13 (0.09) 0.15 (0.08) 0.023
At-fitting tests were taken immediately after dispensing. Control and test measurements were compared in this Table by paired t test.
Only near VA under low contrast was significantly different between spectacle types; however, with a mean difference of 0.02 logMAR
(1 letter on the chart), the difference was not of clinical importance.
HC, high contrast; LC, low contrast.
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Differences in visual performance between test and control spec-
tacles were somewhat more apparent in the novel assessments de-
signed specifically for this PAL trial (Table 3). After 1 week of wear,
distance VA assessed under low contrast at 30° off axis (right side
only; see Discussion) was significantly related to spectacle type
(p 0.002), along with prescription sphere (p 0.001), cylinder
power (p  0.025), standard tilt (p  0.021), subject age (p 
0.016), and a near-significant interaction between spectacle type
and back vertex distance (p  0.055). Overall, younger subjects
with low sphere and cylinder power prescriptions and less frame tilt
had better low contrast distance VA when gazing 30° off axis
through the periphery of the lenses. Significant and potentially
clinically important differences between test and control spectacles
(0.073 logMAR, or3⁄4 of a line on the VA chart) were found for
subjects fitted with shorter back vertex distances (e.g., 9.2 mm, the
smallest observed in our sample).
The most apparent objective difference between the test and
control spectacles was in the horizontal extent of undistorted vision
at reading distance, as measured by the modified Amsler grid after
1 week of wear. The horizontal extent of undistorted near vision
was significantly related to spectacle type (p 0.003), along with
prescription sphere (p  0.034), years of PAL wear (p  0.047),
and significant or near-significant interactions between spectacle
type and segment height (p  0.064), and gender (p  0.041).
Overall, subjects with fewer years of PAL wear had wider fields of
undistorted vision at reading distance. These subjects are, on aver-
age, younger and tended to have lower power prescriptions and
lower addition power. For subjects with segment heights in the
lower end of our fitting range (e.g., below 16 mm), both males and
females found the test spectacles to provide a wider undistorted
field at reading distance, with males finding the field6 cm wider
on average with the test spectacles, and females finding the field
3.5 cm wider. This is most likely due to gender acting as a
confounder, because there is no reason to expect females naturally
to have a more restricted near field on average compared with
males. In univariate unpaired t-tests, gender was significantly re-
lated to the width of the field (p 0.003), as was addition power
(p 0.020), and female subjects had an average of 0.12 D greater
addition power (p  0.021). According to the model, there is
minimal difference (1.6 cm) between test and control spectacles
for subjects with the median segment height we observed (20 mm),
whereas the control spectacles are estimated to have a wider near
field for those fit at the maximum segment height (31 mm).
Although there was no significant difference between test and
control spectacles at dispensing, after adapting to the spectacles for
1 week, 58% of subjects found the test spectacles to have a wider
extent of undistorted near vision, compared with 33% who found
control spectacles to have a wider field, whereas 9% of subjects
found no difference between spectacles (Fig. 1). Ethnicity, educa-
tion level, days per week of PAL wear, amount of driving, reading
or computer usage, and pupillary distance were not significantly
related to any of the objective clinical outcome measures.
Subjective Findings
Despite there being few objective differences of clinical impor-
tance between test and control spectacles, there were significant
differences in subjects’ questionnaire responses. In a direct prefer-
ence comparison after wearing each pair of spectacles for 1 week,
test spectacles were significantly preferred (p  0.001), after ac-
counting for the effects of cylinder power (p  0.003), control
spectacle brand (p  0.002), hours per day of PAL usage (p 
0.010), and back vertex distance (p  0.007). For subjects with
spherical or near-spherical prescriptions (1.5 D of cylinder), the
preference for the test spectacles was strongest among subjects fit
with a medium back vertex distance (11 mm and17 mm) and
wearing non-Zeiss control spectacles and was stronger for subjects
wearing their PAL spectacles for a fewer number of hours per day.
These subjects rated the test spectacles an estimated 1.2 units
higher than the controls on our 6-unit Likert scale. Among subjects
with prescriptions for astigmatism (1.5 D of cylinder), there was
a much stronger preference for the test spectacles. For subjects
wearing non-Zeiss control spectacles, the test spectacles were pre-
ferred for all back vertex distances and wearing times. For subjects
wearing other Zeiss control spectacles, the test spectacles were pre-
ferred for those wearing their PAL spectacles for fewer than the
median number of hours per day and were more strongly preferred
for those fit with medium back vertex distance. These subjects
rated the test spectacles an estimated 2.0 units higher than the
controls on our 6-unit Likert scale.
TABLE 3.
PAL-specific clinical vision assessments
At fitting After 1 week of wear
Control
Mean (SD)
Test
Mean (SD) p
Control
Mean (SD)
Test
Mean (SD) p
Distance VA, HC, off-axis left 0.10 (0.12) 0.10 (0.12) 0.802 0.10 (0.13) 0.10 (0.14) 0.861
Distance VA, HC, off-axis right 0.06 (0.11) 0.06 (0.11) 0.805 0.05 (0.09) 0.04 (0.10) 0.120
Distance VA, LC, off-axis left 0.24 (0.10) 0.24 (0.11) 0.663 0.24 (0.12) 0.24 (0.12) 0.816
Distance VA, LC, off-axis right 0.19 (0.11) 0.19 (0.12) 0.986 0.19 (0.10) 0.16 (0.11) 0.002
Near vision horizontal extent (cm) 20.03 (11.02) 19.19 (11.16) 0.264 17.74 (9.87) 20.06 (11.89) 0.004
At-fitting tests were taken immediately after dispensing. Control and test measurements were compared in this Table by paired t test.
Distance VA off-axis (right side) under low contrast was significantly different between spectacle types; however, with a mean
difference of 0.03 logMAR (1 letter on the chart), the difference was not of clinical importance. The horizontal extent of clear vision
at reading distance was significantly wider with the test lenses after 1 week of wear.
HC, high contrast; LC, low contrast.
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Subjects were also asked a series of forced choice preference
questions for specific viewing distances and modes of PAL usage.
The test spectacles were preferred overall (55% for test vs. 45% for
controls). The test spectacles were also preferred for distance vision
and for active vision (60% for test vs. 40% for controls, in each
case), and for midrange and transitional vision (55% for test vs.
45% for controls, in each case). Subjects indicated no clear prefer-
ence for near vision (50% for test and 50% for controls).
Subjects found the test spectacles to have a significantly shorter
adaptation time (p  0.001) compared with control spectacles,
taking into account significant or near-significant differences in
the distance from the eye to the near vision zone (p 0.060) and
in hours per day of PAL usage (p 0.023). In a pattern similar to
that for the direct preference comparison, subjects who wore their
PAL spectacles for fewer hours per day found adaptation time to be
shorter with the test spectacles, whereas those who wore PAL spec-
tacles more than the median number of hours per day adapted
more quickly to the control spectacles. In addition, adaptation
time was shorter for subjects fit with a medium distance from the
eye to the near vision zone (10 mm and 16 mm). Although
statistically significant, the magnitude of the difference in adapta-
tion time between test and control spectacles was not more than 2
days on average. Approximately 84.2% of subjects were able to
adapt to the control spectacles in 3 days or fewer, as were 85.3% to
the test spectacles, most likely due to all subjects being experienced
PAL wearers before entering the trial and having no drastic changes
in prescription between their habitual spectacles and the study
spectacles. All subjects successfully adapted to both test and control
spectacles within the 1-week wearing period.
Subjects also expressed greater overall satisfaction with the
test spectacles compared with the control spectacles (t-test p 
0.006, Fig. 2). Among subjects who wore other types of Zeiss
PAL spectacles for their controls, slightly greater overall satis-
faction for the control spectacles was reported; with all other
brands of control spectacles, the test spectacles ranked higher in
overall satisfaction. It is interesting to note that with the test
spectacles, most subjects rated their overall satisfaction higher
after adapting to their spectacles for 1 week, whereas with con-
trol spectacles, after 1 week of wear, many subjects reported a
decrease in satisfaction. As expected, adaptation time was a
significant factor in subjects’ overall satisfaction ratings for both
test (t-test, p  0.001) and control spectacles (t-test, p 
0.001). There were no significant associations between any de-
mographic factors, pupillary distance or segment height, and
any of the subjective outcome measures.
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FIGURE 1.
Horizontal extent of undistorted vision at reading distance. Shown in the Figure are the differences (control test) in extent for each subject. The vertical
lines demark those subjects who found the control and test spectacles to have exactly the same extent. At baseline, there was little difference between
test and control. After adapting to the spectacles for 1 week, a much greater percentage of subjects reported a wider undistorted near zone with the test
spectacles.
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DISCUSSION
The purpose of our study was to compare objective clinical
outcomes and subjective wearing experience with customized, free-
form PALs to traditional, non-free-form PALs in an experienced
wearing population. To our knowledge, there has not been a
double-masked randomized, controlled clinical trial comparing
customized free-form progressive lenses to traditional, non-free-
form progressive lenses. Many of the problems patients report with
adapting to and comfortably using PAL spectacles as their primary
presbyopic correction may be due to the optical compromises of
mass lens production, and the inability to take into account indi-
vidual differences in spectacle fit in the design of the lens optics.
The advent of individually customized, free-form PAL spectacles
may offer the potential to minimize some of the commonly re-
ported problems and to provide better vision and a better overall
wearing experience. In this study, we compared customized, free-
form to standard, non-free-form PAL spectacles through standard
objective clinical vision assessments such as would be performed in
a private practice or clinic, and through novel objective assessments
specifically designed to detect more subtle differences in visual
utility between various types of PAL spectacles. Finally, we com-
pared the two types of PAL spectacles in terms of subjective pref-
erences, adaptation times, and overall satisfaction. Ultimately, the
subjective experience of wearing a particular type of PAL spectacle
will be the most important factor in translating our findings into
clinical practice.
Successful visual performance with PAL spectacles (or lack
thereof) is the result of complex interrelationships among the op-
tics of the lenses, the fit of the frame and position of wear, move-
ment of the eyes and head for visual tasks at different viewing
distances, as well as individual characteristics of the patient. Even
so, we found a high rate of success with both control and test
spectacles, probably because of careful fitting by our experienced
opticians. Consequently, standard clinical tests of VA, such as are
routinely performed in private practice or clinic, did not reveal any
clinically important differences between the spectacle types. There
was a statistically significant association between spectacle type and
low-contrast near acuity. Our model suggests that in the clinical
setting, switching full-time PAL wearing patients from some PAL
designs to Zeiss Individual may offer improvement in near VA
under low-contrast conditions. Although statistically significant,
the improvement is approximately half a line on the VA chart, and
thus of marginal clinical importance.
The novel vision assessments developed specifically for this PAL
trial were more sensitive to subtle performance differences between
the test and control spectacles. Low-contrast distance acuity taken
at 30° off axis was significantly better (by3⁄4 of a line on the chart)
with the test spectacles, particularly when spectacles were fit with a
short back vertex distance and a small angle of pantoscopic tilt.
These results suggest that in the clinical setting, patients who are
able to comfortably wear Zeiss Individuals with short back vertex
distances and minimal frame tilt can expect significantly better
off-axis distance vision under low-contrast conditions. It must be
noted that this significant difference was apparent when the chart
was viewed off axis to the right side only. Although technicians
monitored the subjects to ensure that they maintained a straight
forward head position and moved only their eyes to view the chart,
it was not possible to completely immobilize the subjects in the
head positioning apparatus. It is possible that some bias was intro-
duced by a slightly greater ability to turn the head by a few
millimeters to one side but not the other, which was not readily
apparent to the technicians. A bite bar would improve immobili-
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Overall satisfaction. More subjects rated the test spectacles “Very Satisfied” or “Extremely Satisfied” than the controls. No subjects were “Extremely
Dissatisfied” with the test spectacles. The majority of subjects were at least “Slightly Satisfied” with both pairs of spectacles.
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zation but, obviously, make verbal reading of the chart letters im-
possible. We are currently investigating other potential ways to
improve the head positioning apparatus. There is some evidence
that such a left-right asymmetry could also arise from an atten-
tional or reading direction bias, or the cerebral asymmetry of lan-
guage processing.11
The most obvious difference between the test and control spec-
tacles in objective measurements was in the width of the undis-
torted visual field when viewing through the reading (near vision)
zone of the spectacles. Immediately after dispensing, subjects
found little difference between the two pairs. However, after 1
week of wear, when subjects were for the most part fully adapted
and comfortable with the new pair, the test spectacles provided a
wider undistorted reading area, particularly among subjects with
fewer years of PAL wear and fit with low segment height. Fewer
years of PAL wear includes mainly younger subjects with lower add
power, because of their still retaining some degree of accommoda-
tive ability. The improvement with the test lenses was greatest for
smaller segment heights, probably because it is more strenuous and
less comfortable for subjects to down gaze (for example) 30 vs. 16
mm, and then scan their eyes to the right and left.
Differences between test and control spectacles were far more
apparent in the subjective responses. As with the objective tests, the
significant differences became apparent after subjects had adapted
to the spectacles and wore them for 1 week. Subjects preferred the
test lenses for distance vision, active vision, transitional, and
midrange vision, as well as overall. It might be possible that there
was a stronger preference after the week of wear because the sub-
jects were able to discern differences in active, transitional, and
midrange vision, which would not have been immediately appar-
ent until subjects used their PALs for everyday activities, as op-
posed to the limited conditions experienced on dispensing in our
laboratory.
Subjects who had1.5 D of cylinder in their prescriptions, and
who did not wear Zeiss brand controls, particularly preferred the
test spectacles. For astigmatic subjects who wore either GT2 or
Gradal Top for their controls, the preference for the test lenses was
only greater for those who wore their PALs for relatively few hours
per day and were fit with medium back vertex distances. In con-
trast, when compared with other brands of control spectacles, the
test spectacles were significantly preferred for all back vertex dis-
tances and wearing times. Similarly, when each pair of spectacles
was rated on a continuous (0 to 100) scale, the test spectacles rated
significantly higher than other brands of control spectacles but not
when the controls were other models of Zeiss PALs. This might
appear to suggest that subjects prefer Zeiss brands because of the
quality of the optics in general, and that free-form machining and
optical customization do not improve the Zeiss Individual over its
other PAL models. However, we do not believe this to be the case,
because we have found that back vertex distance and pantoscopic
tilt have significant effects on several of our objective and subjective
outcomes, and these are fundamental parameters in the optical
customization of the individual lenses. It is thus still open to spec-
ulation as to why the individual was preferred to other control
spectacles but not to the Zeiss brand controls for some subjects in
this study.
It is interesting to note that we found very little objective differ-
ence in the performance of the test and control spectacles, and yet
there was a clear preference for the test spectacles, particularly for
astigmatic subjects fit with short-to-medium back vertex distances.
In particular, it was surprising that the most obvious objective
difference was the greater horizontal extent of undistorted near
vision, and yet near vision was the only category in which subjects
did not express a preference for the test spectacles. It may be that
although the test spectacles performed better for near vision under
the highly controlled conditions in our laboratory, subjects did not
have a clear preference for one pair or the other for reading or other
near work they did under more natural, day-to-day conditions
during their week of wear outside the laboratory.
Although subjects adapted significantly more quickly to the test
spectacles, the actual difference in adaptation time between the two
was on the order of a few days at most, and nearly all subjects
adapted to both pairs of spectacles within 2 to 4 days. This result is
not surprising in a group of experienced PAL wearers. To deter-
mine whether it is truly easier to adapt to the test spectacles, it
would be more informative to study a group of neophyte PAL
wearers. In this study, we chose to examine experienced PAL wear-
ers because, we knew they would be familiar with how to use PAL
spectacles for a variety of different visual tasks and how to transi-
tion between visual distances, and that they would be able to adapt
to the new lenses quickly, and after 1 week of wear be able to
provide fully practiced objective performance and thoughtful, ex-
perienced subjective impressions.
In conclusion, we have found that PAL spectacle wear can be
improved for many subjects with the Zeiss Individual base design,
optically customized for the prescription, frame size, and fitting
parameters, combined with free-form manufacturing, to provide
each patient with spectacles tailored to his or her specific charac-
teristics. We did not find any important objective differences be-
tween customized free-form PALs and standard non-free-form
PALs in standard clinical vision assessments. It may be that such
objective performance differences do not exist. However, it may be
that standard clinical tests are not sufficiently refined to detect
subtle performance differences. We did find that it is possible to
design vision tests to detect differences in objective performance
that are specific to the visual utility of PAL spectacles. Without the
more refined objective assessments, the clinician must rely almost
entirely on the patient’s subjective responses to achieve the opti-
mum wearing experience with PAL spectacles.
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